Cargando…
Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055910/ https://www.ncbi.nlm.nih.gov/pubmed/32133433 http://dx.doi.org/10.1200/PO.19.00287 |
_version_ | 1783503448047616000 |
---|---|
author | Hemming, Matthew L. Nathenson, Michael J. Lin, Jia-Ren Mei, Shaolin Du, Ziming Malik, Karan Marino-Enriquez, Adrian Jagannathan, Jyothi P. Sorger, Peter K. Bertagnolli, Monica Sicinska, Ewa Demetri, George D. Santagata, Sandro |
author_facet | Hemming, Matthew L. Nathenson, Michael J. Lin, Jia-Ren Mei, Shaolin Du, Ziming Malik, Karan Marino-Enriquez, Adrian Jagannathan, Jyothi P. Sorger, Peter K. Bertagnolli, Monica Sicinska, Ewa Demetri, George D. Santagata, Sandro |
author_sort | Hemming, Matthew L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7055910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society of Clinical Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-70559102020-03-04 Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1 Hemming, Matthew L. Nathenson, Michael J. Lin, Jia-Ren Mei, Shaolin Du, Ziming Malik, Karan Marino-Enriquez, Adrian Jagannathan, Jyothi P. Sorger, Peter K. Bertagnolli, Monica Sicinska, Ewa Demetri, George D. Santagata, Sandro JCO Precis Oncol Case Reports American Society of Clinical Oncology 2020-02-14 /pmc/articles/PMC7055910/ /pubmed/32133433 http://dx.doi.org/10.1200/PO.19.00287 Text en © 2020 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution Non-Commercial No Derivatives 4.0 License https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Case Reports Hemming, Matthew L. Nathenson, Michael J. Lin, Jia-Ren Mei, Shaolin Du, Ziming Malik, Karan Marino-Enriquez, Adrian Jagannathan, Jyothi P. Sorger, Peter K. Bertagnolli, Monica Sicinska, Ewa Demetri, George D. Santagata, Sandro Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1 |
title | Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1 |
title_full | Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1 |
title_fullStr | Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1 |
title_full_unstemmed | Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1 |
title_short | Response and Mechanisms of Resistance to Larotrectinib and Selitrectinib in Metastatic Undifferentiated Sarcoma Harboring Oncogenic Fusion of NTRK1 |
title_sort | response and mechanisms of resistance to larotrectinib and selitrectinib in metastatic undifferentiated sarcoma harboring oncogenic fusion of ntrk1 |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055910/ https://www.ncbi.nlm.nih.gov/pubmed/32133433 http://dx.doi.org/10.1200/PO.19.00287 |
work_keys_str_mv | AT hemmingmatthewl responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT nathensonmichaelj responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT linjiaren responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT meishaolin responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT duziming responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT malikkaran responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT marinoenriquezadrian responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT jagannathanjyothip responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT sorgerpeterk responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT bertagnollimonica responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT sicinskaewa responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT demetrigeorged responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 AT santagatasandro responseandmechanismsofresistancetolarotrectinibandselitrectinibinmetastaticundifferentiatedsarcomaharboringoncogenicfusionofntrk1 |